Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Gustafson

Showing results (101-110 of 127) with videos related to

Pageof 13
Sort By:
Clinical & Experimental Metastasis|June 11, 2020
The clinical efficacy of PSMA PET/MRI in biochemically recurrent prostate cancer compared with standard of care imaging modalities and confirmatory histopathology: results of a single-centre, prospective clinical trialA Joshi, M J Roberts, M Perera, et al.
Annals of Surgical Oncology|July 27, 2020
Omission of Axillary Lymph Node Dissection is Associated with Inferior Survival in Breast Cancer Patients with Residual N1 Nodal Disease Following Neoadjuvant ChemotherapyMuayad F Almahariq, Ronald Levitin, Thomas J Quinn, et al.
Cancer|September 1, 1996
Excellent functional outcome in patients with squamous cell carcinoma of the base of tongue treated with external irradiation and interstitial iodine 125 boostE M Horwitz, A J Frazier, A A Martinez, et al.
Inflammopharmacology|November 2, 2005
The inhibition of neutrophil-endothelial cell adhesion by hyaluronan independent of CD44C A S Alam, M P Seed, C Freemantle, et al.
The Cancer Journal From Scientific American|December 24, 1997
Conformal high dose rate iridium-192 boost brachytherapy in locally advanced prostate cancer: superior prostate-specific antigen response compared with external beam treatmentJ S Stromberg, A A Martinez, E M Horwitz, et al.
International Journal of Radiation Oncology, Biology, Physics|May 21, 2011
Prognostic significance of neuroendocrine differentiation in patients with Gleason score 8-10 prostate cancer treated with primary radiotherapyDaniel J Krauss, Sylvia Hayek, Mitual Amin, et al.
International Journal of Radiation Oncology, Biology, Physics|July 21, 2005
Dose-volume analysis of predictors for chronic rectal toxicity after treatment of prostate cancer with adaptive image-guided radiotherapyCarlos Vargas, Alvaro Martinez, Larry L Kestin, et al.
Urology|July 5, 2011
Clinical Stage T1 micropapillary urothelial carcinoma presenting with metastasis to the pancreasDaniel Canter, Jay Simhan, Marc C Smaldone, et al.
Advances in Radiation Oncology|March 10, 2023
Normal Tissue Integral Dose as a Result of Prostate Radiation Therapy: A Quantitative Comparison Between High-Dose-Rate Brachytherapy and Modern External Beam Radiation Therapy TechniquesVincent P Grzywacz, Jessica D Arden, Nikhil P Mankuzhy, et al.
International Journal of Radiation Oncology, Biology, Physics|November 13, 2020
Long-Term Results of NRG Oncology/RTOG 0321: A Phase II Trial of Combined High Dose Rate Brachytherapy and External Beam Radiation Therapy for Adenocarcinoma of the ProstateI-Chow Hsu, Joseph P Rodgers, Katsuto Shinohara, et al.
Pageof 13

Showing results (101-110 of 127) with videos related to

Sort By:
Pageof 13
Clinical & Experimental Metastasis|June 11, 2020
The clinical efficacy of PSMA PET/MRI in biochemically recurrent prostate cancer compared with standard of care imaging modalities and confirmatory histopathology: results of a single-centre, prospective clinical trialA Joshi, M J Roberts, M Perera, et al.
Annals of Surgical Oncology|July 27, 2020
Omission of Axillary Lymph Node Dissection is Associated with Inferior Survival in Breast Cancer Patients with Residual N1 Nodal Disease Following Neoadjuvant ChemotherapyMuayad F Almahariq, Ronald Levitin, Thomas J Quinn, et al.
Cancer|September 1, 1996
Excellent functional outcome in patients with squamous cell carcinoma of the base of tongue treated with external irradiation and interstitial iodine 125 boostE M Horwitz, A J Frazier, A A Martinez, et al.
Inflammopharmacology|November 2, 2005
The inhibition of neutrophil-endothelial cell adhesion by hyaluronan independent of CD44C A S Alam, M P Seed, C Freemantle, et al.
The Cancer Journal From Scientific American|December 24, 1997
Conformal high dose rate iridium-192 boost brachytherapy in locally advanced prostate cancer: superior prostate-specific antigen response compared with external beam treatmentJ S Stromberg, A A Martinez, E M Horwitz, et al.
International Journal of Radiation Oncology, Biology, Physics|May 21, 2011
Prognostic significance of neuroendocrine differentiation in patients with Gleason score 8-10 prostate cancer treated with primary radiotherapyDaniel J Krauss, Sylvia Hayek, Mitual Amin, et al.
International Journal of Radiation Oncology, Biology, Physics|July 21, 2005
Dose-volume analysis of predictors for chronic rectal toxicity after treatment of prostate cancer with adaptive image-guided radiotherapyCarlos Vargas, Alvaro Martinez, Larry L Kestin, et al.
Urology|July 5, 2011
Clinical Stage T1 micropapillary urothelial carcinoma presenting with metastasis to the pancreasDaniel Canter, Jay Simhan, Marc C Smaldone, et al.
Advances in Radiation Oncology|March 10, 2023
Normal Tissue Integral Dose as a Result of Prostate Radiation Therapy: A Quantitative Comparison Between High-Dose-Rate Brachytherapy and Modern External Beam Radiation Therapy TechniquesVincent P Grzywacz, Jessica D Arden, Nikhil P Mankuzhy, et al.
International Journal of Radiation Oncology, Biology, Physics|November 13, 2020
Long-Term Results of NRG Oncology/RTOG 0321: A Phase II Trial of Combined High Dose Rate Brachytherapy and External Beam Radiation Therapy for Adenocarcinoma of the ProstateI-Chow Hsu, Joseph P Rodgers, Katsuto Shinohara, et al.
Pageof 13